- Home
- CNSP vs CPHI Comparison
CNSP vs CPHI Comparison
Compare CNSP & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- CPHI
- Stock Information
- Founded
- CNSP 2017
- CPHI N/A
- Country
- CNSP United States
- CPHI China
- Employees
- CNSP N/A
- CPHI N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- CNSP Health Care
- CPHI Health Care
- Exchange
- CNSP Nasdaq
- CPHI Nasdaq
- Market Cap
- CNSP 5.6M
- CPHI 4.5M
- IPO Year
- CNSP 2019
- CPHI N/A
- Fundamental
- Price
- CNSP $1.04
- CPHI $1.65
- Analyst Decision
- CNSP Hold
- CPHI
- Analyst Count
- CNSP 1
- CPHI 0
- Target Price
- CNSP N/A
- CPHI N/A
- AVG Volume (30 Days)
- CNSP 224.0K
- CPHI 119.7K
- Earning Date
- CNSP 05-14-2025
- CPHI 05-14-2025
- Dividend Yield
- CNSP N/A
- CPHI N/A
- EPS Growth
- CNSP N/A
- CPHI N/A
- EPS
- CNSP N/A
- CPHI N/A
- Revenue
- CNSP N/A
- CPHI $4,528,929.00
- Revenue This Year
- CNSP N/A
- CPHI N/A
- Revenue Next Year
- CNSP N/A
- CPHI N/A
- P/E Ratio
- CNSP N/A
- CPHI N/A
- Revenue Growth
- CNSP N/A
- CPHI N/A
- 52 Week Low
- CNSP $0.77
- CPHI $1.20
- 52 Week High
- CNSP $800.00
- CPHI $4.10
- Technical
- Relative Strength Index (RSI)
- CNSP 36.68
- CPHI 42.78
- Support Level
- CNSP $0.83
- CPHI $1.34
- Resistance Level
- CNSP $1.37
- CPHI $1.71
- Average True Range (ATR)
- CNSP 0.15
- CPHI 0.28
- MACD
- CNSP 0.07
- CPHI 0.00
- Stochastic Oscillator
- CNSP 44.82
- CPHI 37.38
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.